Sobi Receives Approval from Health Canada for Empaveli (pegcetacoplan) for the Treatment of Certain…
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that Health Canada has approved Empaveli™ (pegcetacoplan), a complement inhibitor, for the…
Read More...
Read More...
